Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001762572-26-000004

Chief Patient Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hoitt Jason Chief Patient Officer 2026-03-15 Option exercise +10,000 13,988 D
Derivatives
Hoitt Jason Chief Patient Officer 2026-03-15 Option exercise · Restricted Stock Units −10,000 30,000 D
Loading xslF345X05/form4-03172026_090347.xml…